CENTESSA PHARMACEUTICALS PLC Current Assets
CENTESSA PHARMACEUTICALS PLC had Current Assets of $348.68 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-05-05
- 2026-03-31: Assets, Current $348.68M.
- 2025-12-31: Assets, Current $367.88M.
- 2025-09-30: Assets, Current $307.68M.
- 2025-06-30: Assets, Current $300.36M.
| Period end | Assets, Current |
|---|---|
| 2026-03-31 | $348.68M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $367.88M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $307.68M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $300.36M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $347.72M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $536.41M 10-K · filed 2026-03-31 |
| 2024-09-30 | $568.36M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $355.50M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $284.48M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $315.09M 10-K · filed 2025-03-24 |
| 2023-09-30 | $332.45M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $350.41M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $384.33M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $437.75M 10-K · filed 2024-03-28 |
| 2022-09-30 | $476.99M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $519.50M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $581.20M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $628.77M 10-K · filed 2023-03-30 |
| 2021-09-30 | $611.64M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $643.68M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $11.16M 10-K · filed 2022-03-30 |